Article Versions Notes

Kokot A, Gadakh S, Saha I, Gajda E, Łaźniewski M, Rakshit S, Sengupta K, Mollah AF, Denkiewicz M, Górczak K, et al. Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer. Current Issues in Molecular Biology. 2024; 46(3):2713-2740. https://doi.org/10.3390/cimb46030171

Kokot, Anna, Sachin Gadakh, Indrajit Saha, Ewa Gajda, Michał Łaźniewski, Somnath Rakshit, Kaustav Sengupta, Ayatullah Faruk Mollah, Michał Denkiewicz, Katarzyna Górczak, and et al. 2024. "Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer" Current Issues in Molecular Biology 46, no. 3: 2713-2740. https://doi.org/10.3390/cimb46030171

Kokot, A., Gadakh, S., Saha, I., Gajda, E., Łaźniewski, M., Rakshit, S., Sengupta, K., Mollah, A. F., Denkiewicz, M., Górczak, K., Claesen, J., Burzykowski, T., & Plewczynski, D. (2024). Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer. Current Issues in Molecular Biology, 46(3), 2713-2740. https://doi.org/10.3390/cimb46030171